Oxygen for Everyone

Home|Oxygen for Everyone
Oxygen Concentrators

In partnership with

India, in the middle of the second wave of COVID-19, needs to rapidly augment oxygen supply to hospitals. In order to save as many lives as possible, ACT, Swasth Alliance (a not-for-profit alliance of over 150+ healthcare organizations) and Feeding India (a not-for-profit run by Zomato) are working towards the goal of sourcing and distributing
50,000 oxygen concentrators.

These oxygen concentrators will be donated to various public health institutions and NGOs working for public health across India. Delhivery (logistics partner), Temasek Foundation (Sourcing and Funding partner), Paytm (Sourcing partner) and several others from the ecosystem are supporting this effort. MyGov is supporting the initiative by ensuring proper coordination with various stakeholders involved, particularly District Collectors, for most optimal utilization of the oxygen concentrators.

How are we deploying these concentrators?

We have set a goal of 50,000 oxygen concentrators. However, the actual demand on the ground is far larger. Demand for oxygen concentrators from the frontline is being collected through a form hosted by the Swasth Alliance for all and on MyGov.in for District Collectors (https://self4society.mygov.in/collector). Various district magistrates, state governments and not-for-profit healthcare providers are required to fill in their requirements of oxygen concentrators in this form.

Allocation is based on the principles of Equity, Transparency and Impact. You can see below for more details on how we allocate the concentrators to different healthcare institutions. You can see the full list of oxygen concentrator recipients through Swasth’s deployment dashboard linked below.

How are we allocating the Oxygen concentrators?

Allocation is based on three guiding principles: Equity, Transparency and Impact.

Equity

We use data-driven decision-making to identify areas and facilities most in need to allocate the limited supply of oxygen concentrators. While the media focus in the current crisis is on major urban centres, the principle of equity dictates that we also work on supporting rural districts that have far less infrastructure, resources and visibility in the mainstream and social media.

To support the principle of inclusion of the poor and marginalized sections of society, our distribution is prioritizing public health facilities and charitable hospitals.

Impact

We are looking to deploy Oxygen concentrators in the most impacted regions, as rapidly as possible. To identify these regions, we have developed a methodology which leverages epidemiological data to allocate concentrators across districts of India.

This methodology takes into account publicly available COVID-19 data, and is further refined using predictive analytics generated by the Aarogya Setu ITIHAS interface (Developed by IIT Madras) for emerging hotspots.

Transparency

We are committed to transparency. All details of OCs distributed will be published in the public domain on the MyGov, ACT and Swasth Alliance website. The methodology is published on MyGov (mygov.in), Swasth (swasth.app) and ACT websites, along with district-level distribution of oxygen concentrators

PSA Plants

PSA plants (Pressure Swing Adsorption Plants) generate oxygen from the air and are the long term oxygen solution – safe and sustainable. Our goal is to have 100 PSAs installed by June 2021. The PSA Plants are being sourced from top vendors like Tata Advanced Systems, Labh Group, Ausmedi Kavia (to name a few) and being donated to various public health institutions and hospitals in India. We have several installation partners – Zetwerk, Cleanmax, Oyo who are overlooking hospital-vendor interaction for timely implementation.

Benefits of PSA Plants

  •  Augmenting oxygen capacity of hospitals
    • PSA plants can cover up to 70% of a hospital’s oxygen requirement 
  • Increases the country’s oxygen capacity
    • Generate net new oxygen so increases total supply and builds long term capability 
  • No transportation constraint
    • No logistical constraints of transporting large quantities of oxygen

ACTion Updates

100

PSA plants by June 2021
(Goal)

105

PSA plants procured

18

PSA plants installed
FAQs

What is an oxygen concentrator?

  • Oxygen concentrators are alternate devices to oxygen cylinders – while cylinders contain a finite amount of oxygen supply, a concentrator recycles oxygen from the air and delivers it to the patient. They can be used to manage patient requirements without looking for external sources of oxygen.

Type of concentrator

  • We are focused on procuring 10LPM concentrators as they have most impact on saving lives and hence work mostly with suppliers who have them or can make them available in short order. We are also procuring other concentrators, such as 5LPM, depending on need and availability.

Where are you procuring these from?

  • Concentrators are being sourced from multiple manufacturers and their distributors. Some of the manufacturers we work with include Yuwell, BPL, Medequip, Nidek, Sanrai depending upon who has availability at our time of need.

Where are you giving these?

  • We are sourcing needs from across the country using a variety of networks of people on the ground. We will supply across the country based on a process of demand and supply matching. All details of demand, supply, the matching process and the final distribution will be made available in the public domain as we wish to be as transparent as possible.

What is the quality of these oxygen concentrators?

  • We are a not-for-profit facilitating various COVID-19 relief projects, including sourcing and distribution of oxygen concentrators throughout India at the request of Recipients in need. We do not have the required medical expertise to evaluate or test, and are not responsible for, the quality, functioning or usage of any medical equipment. We request all Recipients to evaluate the functionality of these oxygen concentrators before use. Please read our terms and conditions around medical or other liabilities and indemnity here. Recipients may use the oxygen concentrators after proper evaluation about the manufacturers, details of which are provided to the Recipients. 

  • We are providing the below information regarding the quality checks we have conducted at our end as part of our due diligence. Recipients may go through this to inform themselves better.

    • Supplier verification: We are working with a large base of suppliers, whom we evaluate through a vendor due diligence and specifications alignment, across the world. You can find relevant vendor certifications here (updated as on 12 May).

    • Monitoring & Evaluation: We are conducting periodic check-ins with medical facilities where the concentrators have been deployed for feedback on their quality and utilization from doctors

    • Sample calibration: We have conducted calibration of 80 devices from different vendors through an NABL-Accredited Calibration Lab. Please click here to see the report. We do not intend to carry out any further sample calibration. 

  • We are on a mission to save as many lives as possible, rapidly augmenting supply of oxygen at medical facilities. We will not calibrate devices any further in order to stay true to this and deliver oxygen concentrators as quickly as possible.

What about the logistics?

  • We are ensuring end-to-end tracking of deliveries with acknowledgements from recipients with the support of our logistic partners such as Amazon and Delhivery.

How soon will you start distributing?

  • We have already started the process of distribution. We have supply tie-ups lined up and will continue to increase orders as we raise funds.

How do I know what impact my contribution has?

  • You can view demand requests received, supply procured and the matching process. You will be able to see the exact impact your contribution is making.

Can we contribute to specific cities or hospitals?

  • Unfortunately, we cannot direct contributions to specific hospitals or cities at this time. We have a constantly updated list of which providers are most in need and we will use this to allocate the concentrators.

Who are the suppliers you engage with?

  • We are engaging with suppliers of repute that have the capacity to supply 10LPM concentrators. A representative list of suppliers include the following (some we have worked with, some we haven’t)

    • Airsep

    • Fisher & Paykel Healthcare

    • Respironics Inc.

    • Aptar France Sas

    • Invacare

    • Rpc Formatec Gmb H

    • Biome Healthcare

    • Longfian Scitech Co., Ltd.

    • Shenzhen Zhaoli Motor Co., Ltd.

    • Bmc Medical Co., Ltd.

    • MedEquip

    • Smiths Medical International

    • BPL

    • Nidek

    • Xiamen Health Reach Co., Ltd.

    • Dedeakj

    • Philips Respironics

    • Yazaki De Nicaragua Sa

    • Dragerwerk Ag & Co. Kgaa

    • Presspart Mfg. S.A

    • Yuwell

    • Eloxy Technology

    • Resmed Asia Operations (Pty)

 

 

What is a PSA plant?

  • PSA plants generate oxygen by extracting it from air. They do so by using the PSA (Pressure Swing Adsorption) process which is a purely physical process that drives separation of oxygen from air.

What are the costs of PSA plants?

  • The average cost of a 500 LPM PSA plant is ~USD 100k (INR 75 Lakhs). These prices have spiked up during the ongoing COVID-19 crisis due to lack of supply and raw materials like Zeolite.

Where are we procuring these from?

  • We are procuring these from some of the top vendors including Tata Advanced Systems Limited, Airox Technologies, Ausmedi Kavia, Meditech, Labh Group, Ozcan, Advanced Pneumatics and PCI Gas. Our partners and advisors include CleanMax, Linde and Tata Consulting Engineers Limited.

Where are we giving these?

  • We are prioritizing demand based on the following principles:

    • District/state prioritisation: We are conducting a macro-level demand forecasting and analysis of virus hotspots and oxygen-deficient areas through available forecasts from the Govt. of India, State Govts as well as other epidemiological studies. The team is overlaying this with information on available oxygen resources in different Indian states as well as planned initiatives to augment the oxygen supply by the Central and State Governments

    • Demand Aggregation of Hospitals: In identified hotspots, local partners/ govt officials/medical bodies like IMA are being reached out to, to get a list of hospitals. The demand team has created a google request form to be filled out by the hospital administration to capture all relevant information.

    • Technical Review: Our demand verification team is conducting a secondary review to check the information provided through open sources and is administering a follow-up interview to check the infrastructural capacity of the hospitals.